RWE
Pronunciation: R-W-E
Also written as: RWE — Real-World Evidence
Real-World Evidence derived from analysis of real-world data to support regulatory decisions and clinical practice in oncology.
Full Definition
Real-World Evidence (RWE) is clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of real-world data. In oncology, RWE complements traditional clinical trial data by providing insights into how treatments perform in routine clinical practice across diverse patient populations. RWE sources include electronic health records, claims databases, patient registries, and patient-reported outcomes collected outside of controlled clinical trials. Regulatory agencies increasingly use RWE to support drug approvals, label expansions, and post-market surveillance. The evidence helps bridge the gap between controlled trial results and real-world treatment outcomes.
Usage
Usage note: Distinguish from RWD (Real-World Data); RWE is the analysis and insights derived from RWD.
In Context
- "The pharmaceutical company submitted RWE to support the drug's effectiveness in elderly patients with multiple comorbidities." — Regulatory filing documentation
- "RWE analysis demonstrated that the treatment maintained effectiveness across diverse real-world patient populations." — Post-market surveillance report